| |
| |
|
| Insider
Information: |
Swayze Eric |
| Relationship: |
Officer Level 14 |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
34,929 |
|
|
Indirect Shares
|
85 |
|
|
| Direct
Value |
$1,429,644 |
|
|
|
Indirect Value
|
$3,479 |
|
|
| Total
Shares |
35,014 |
|
|
| Total
Value |
$1,433,123 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Officer Level 14 |
2024-02-29 |
34,929 |
2024-02-29 |
85 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Officer Level 14 |
• – – |
2024-02-29 |
4 |
A |
$34.43 |
$20,827 |
D/D |
605 |
34,929 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2024-02-02 |
4 |
S |
$49.56 |
$94,513 |
D/D |
(1,907) |
34,324 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,715 |
36,231 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2024-01-31 |
4 |
S |
$52.00 |
$560,196 |
D/D |
(10,773) |
32,516 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2024-01-17 |
4 |
S |
$50.42 |
$454 |
I/I |
(9) |
85 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2024-01-17 |
4 |
S |
$50.42 |
$317,425 |
D/D |
(6,296) |
43,289 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2024-01-16 |
4 |
OE |
$0.00 |
$0 |
I/I |
21 |
94 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2024-01-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,069 |
49,585 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2023-12-28 |
4 |
OE |
$47.34 |
$1,282,914 |
D/D |
27,100 |
59,616 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2023-12-28 |
4 |
S |
$50.19 |
$1,360,081 |
D/D |
(27,100) |
32,516 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2023-10-17 |
4 |
S |
$47.95 |
$2,493 |
I/I |
(52) |
73 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2023-10-16 |
4 |
OE |
$0.00 |
$0 |
I/I |
125 |
125 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2023-02-28 |
4 |
A |
$30.52 |
$17,546 |
D/D |
575 |
32,516 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2023-02-06 |
4 |
S |
$40.79 |
$74,031 |
D/D |
(1,815) |
31,941 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2023-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,715 |
33,756 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2023-01-18 |
4 |
S |
$39.74 |
$223,800 |
D/D |
(5,631) |
30,041 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2023-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,780 |
35,672 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2022-09-08 |
4 |
AS |
$44.55 |
$20,493 |
D/D |
(460) |
19,892 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2022-08-05 |
4 |
AS |
$45.20 |
$45 |
D/D |
(1) |
20,352 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2022-04-21 |
4 |
AS |
$44.15 |
$16,689 |
D/D |
(378) |
20,353 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2022-02-28 |
4 |
A |
$28.37 |
$17,620 |
D/D |
621 |
20,731 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2022-01-18 |
4 |
D |
$30.12 |
$150,419 |
D/D |
(4,994) |
20,110 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Research |
• – – |
2022-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,809 |
25,104 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Research |
• – – |
2021-02-26 |
4 |
A |
$44.54 |
$20,488 |
D/D |
460 |
11,295 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Research |
• – – |
2021-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,944 |
14,051 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
